| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 69.58B | 68.47B | 63.73B | 56.98B | 52.21B | 49.84B |
| Gross Profit | 36.46B | 36.17B | 33.72B | 29.10B | 28.05B | 27.71B |
| EBITDA | 30.75B | 30.53B | 27.54B | 24.37B | 24.61B | 24.23B |
| Net Income | 24.05B | 23.80B | 22.19B | 18.06B | 18.89B | 17.62B |
Balance Sheet | ||||||
| Total Assets | 87.03B | 101.35B | 99.36B | 92.76B | 87.35B | 82.84B |
| Cash, Cash Equivalents and Short-Term Investments | 42.75B | 63.11B | 54.45B | 54.66B | 50.13B | 48.01B |
| Total Debt | 369.00M | 456.00M | 429.61M | 694.02M | 833.85M | 697.61M |
| Total Liabilities | 19.50B | 17.73B | 20.77B | 18.17B | 16.35B | 14.35B |
| Stockholders Equity | 67.52B | 83.62B | 78.59B | 74.59B | 71.00B | 68.49B |
Cash Flow | ||||||
| Free Cash Flow | 20.15B | 21.64B | 17.61B | 17.20B | 18.19B | 19.01B |
| Operating Cash Flow | 20.59B | 21.99B | 17.91B | 17.58B | 18.56B | 19.20B |
| Investing Cash Flow | -11.17B | -24.53B | 15.98B | 1.37B | -1.67B | 458.13M |
| Financing Cash Flow | -23.20B | -20.96B | -19.58B | -16.65B | -17.33B | -15.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ₹403.07B | 30.05 | ― | 1.94% | 8.73% | 11.33% | |
72 Outperform | ₹604.45B | 27.42 | ― | 5.05% | 2.78% | -5.10% | |
69 Neutral | ₹772.45B | 55.70 | ― | 0.55% | 23.27% | 33.09% | |
66 Neutral | ₹1.25T | 46.27 | ― | 1.08% | 8.72% | 4.54% | |
64 Neutral | ₹87.19B | 33.59 | ― | 2.62% | 1.68% | -12.95% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | ₹1.36T | 31.42 | ― | 2.76% | 3.30% | 36.78% |